Related Experiment Video
Updated: Oct 13, 2025

Fluorescence Microscopy for ATP Internalization Mediated by Macropinocytosis in Human Tumor Cells and Tumor-xenografted Mice
Published on: June 30, 2021
ATP binding cassette transporters and cancer: revisiting their controversial role
Parul Sharma1, Navneet Singh2, Siddharth Sharma1
1Department of Biotechnology, Thapar Institute of Engineering & Technology, Patiala, India.
Abstract:
The expression of ATP-binding cassette transporter (ABC transporters) has been reported in various tissues such as the lung, liver, kidney, brain and intestine. These proteins account for the efflux of different compounds and metabolites across the membrane, thus decreasing the concentration of the toxic compounds. ABC transporter genes play a vital role in the development of multidrug resistance, which is the main obstacle that hinders the success of chemotherapy. Preclinical and clinical trials have investigated the probability of overcoming drug-associated resistance and substantial toxicities. The focus has been put on several strategies to overcome multidrug resistance. These strategies include the development of modulators that can modulate ABC transporters. This knowledge can be translated for clinical oncology treatment in the future.
Insights
ATP-binding cassette (ABC) transporters are crucial in drug resistance and chemotherapy. Modulating these transporters offers a promising strategy to overcome multidrug resistance in cancer treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- ATP-binding cassette (ABC) transporters are membrane proteins involved in efflux of compounds.
- ABC transporters are expressed in various human tissues, including lung, liver, kidney, brain, and intestine.
- These transporters play a critical role in the development of multidrug resistance (MDR), a major challenge in cancer chemotherapy.
Purpose of the Study:
- To review the role of ABC transporters in multidrug resistance.
- To explore strategies for overcoming ABC transporter-mediated drug resistance.
- To discuss the potential clinical applications of modulating ABC transporters in oncology.
Main Methods:
- Literature review of preclinical and clinical studies on ABC transporters and multidrug resistance.
- Analysis of the mechanisms by which ABC transporters contribute to drug efflux and resistance.
- Evaluation of therapeutic strategies targeting ABC transporters.
Main Results:
- ABC transporters facilitate the efflux of various compounds, reducing intracellular drug concentrations.
- Overexpression of ABC transporters is a key mechanism underlying multidrug resistance in cancer.
- Modulators of ABC transporters are being investigated to enhance chemotherapy efficacy.
Conclusions:
- Targeting ABC transporters is a viable strategy to overcome multidrug resistance.
- Further research and clinical trials are needed to translate these findings into effective cancer treatments.
- Modulation of ABC transporters holds promise for improving patient outcomes in oncology.
More Related Videos
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

